Takeda - Better Health, Brighter Future

Enable Accessibility Enable Accessibility

Better Health, Brighter Future

Harnessing the Power of People to Transform Health Care

LEARN MORE

Welcome to the Global
Corporate Website for Takeda

If you are looking for specific information,
please visit our country/region website.

SELECT A COUNTRY OR REGION SITE

FY2020 Q2 Financial Results Highlights

Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

RECENT NEWS STOCK PRICE

Dec 18, 2020 Dec 18, 2020

U.S. FDA Approves Supplemental New Drug Application for Takeda’s ICLUSIG^® (ponatinib) for Adult Patients with Resistant or Intolerant Chronic-Phase CML

Please wait...

Topics

Using a Global Network of Adaptive Clinical Trials to Fight COVID-19

Improving Access to Healthcare in Remote Communities

COVID-19 Information Center

FY2020 Q2 Financial Results

Information

Wave 1 Pipeline Market Opportunity Call (to be held on December 8, 2020)

Information for US Patients Regarding the NATPARA Recall in the US

Offer for Shire plc

Copyright 1995-2020 Takeda Pharmaceutical Company Limited. All rights reserved.